• Je něco špatně v tomto záznamu ?

First experiences with Miethke M.blue® valve in iNPH patients

P. Skalický, A. Mládek, A. Vlasák, H. Whitley, O. Bradáč

. 2022 ; 98 (-) : 127-132. [pub] 20220215

Jazyk angličtina

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018993

The literature on hydrocephalus treatment shows support for adjustable valves and devices which prevent the so-called "siphon effect". In our study, 21 probable iNPH patients were indicated to shunt surgery with the Miethke M.blue® adjustable gravitational valve. Outcomes at three months were measured using the following tests: Dutch Gait Scale, International Consortium on Incontinence Questionnaire (ICIQ-UI SF), SF12V2-Health Survey, Kiefer Scale, 3T MRI, and a neuropsychological testing battery. Preoperative parameters were studied for any signs of overdrainage risk. Valves were set according to the manufacturer's recommendations. Significant improvement at three months was seen in the Dutch Gait Scale, ICIQ-UI SF, Kiefer Scale, Mental Health Component of the SF12V2-Health Survey (MCS-12) and three neuropsychological tests: Rey-Osterrieth complex figure test (ROCFT 30 min), auditory verbal learning test (AVLT I-V) and the NKP version of verbal fluency test. Seven patients needed more than one adjustment of the valve. This subgroup significantly improved only in Walking Score and Step Score but the trend was toward significant improvement in other variables. Eight patients had subdural effusions that were completely managed with adjustments until the 3-month control. BMI was significantly lower in patients with ≥2 adjustments compared to those with a maximum of one adjustment. Implantation had low complication rates and no mortality. Initial results are promising however more studies are needed to provide rationale for gravitational valves in iNPH. We recommend increasing the initial valve setting by 2-4 cm H2O above manufacturer's recommendation, especially in lean patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018993
003      
CZ-PrNML
005      
20220804135242.0
007      
ta
008      
220720s2022 stk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jocn.2022.02.004 $2 doi
035    __
$a (PubMed)35180501
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a stk
100    1_
$a Skalický, Petr $u Department of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
245    10
$a First experiences with Miethke M.blue® valve in iNPH patients / $c P. Skalický, A. Mládek, A. Vlasák, H. Whitley, O. Bradáč
520    9_
$a The literature on hydrocephalus treatment shows support for adjustable valves and devices which prevent the so-called "siphon effect". In our study, 21 probable iNPH patients were indicated to shunt surgery with the Miethke M.blue® adjustable gravitational valve. Outcomes at three months were measured using the following tests: Dutch Gait Scale, International Consortium on Incontinence Questionnaire (ICIQ-UI SF), SF12V2-Health Survey, Kiefer Scale, 3T MRI, and a neuropsychological testing battery. Preoperative parameters were studied for any signs of overdrainage risk. Valves were set according to the manufacturer's recommendations. Significant improvement at three months was seen in the Dutch Gait Scale, ICIQ-UI SF, Kiefer Scale, Mental Health Component of the SF12V2-Health Survey (MCS-12) and three neuropsychological tests: Rey-Osterrieth complex figure test (ROCFT 30 min), auditory verbal learning test (AVLT I-V) and the NKP version of verbal fluency test. Seven patients needed more than one adjustment of the valve. This subgroup significantly improved only in Walking Score and Step Score but the trend was toward significant improvement in other variables. Eight patients had subdural effusions that were completely managed with adjustments until the 3-month control. BMI was significantly lower in patients with ≥2 adjustments compared to those with a maximum of one adjustment. Implantation had low complication rates and no mortality. Initial results are promising however more studies are needed to provide rationale for gravitational valves in iNPH. We recommend increasing the initial valve setting by 2-4 cm H2O above manufacturer's recommendation, especially in lean patients.
650    _2
$a následné studie $7 D005500
650    _2
$a gravitace $7 D006112
650    _2
$a lidé $7 D006801
650    12
$a normotenzní hydrocefalus $x diagnóza $x chirurgie $7 D006850
650    _2
$a výsledek terapie $7 D016896
650    _2
$a ventrikuloperitoneální zkrat $x metody $7 D017287
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mládek, Arnošt $u Department of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Department of Cognitive Systems and Neurosciences, Czech Institute of Informatics, Robotics and Cybernetics, Czech Technical University, Prague, Czech Republic
700    1_
$a Vlasák, Aleš $u Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Whitley, Helen $u Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Bradáč, Ondřej $u Department of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Department of Neurosurgery, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Electronic address: ondrej.bradac@uvn.cz
773    0_
$w MED00166944 $t Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia $x 1532-2653 $g Roč. 98, č. - (2022), s. 127-132
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35180501 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135235 $b ABA008
999    __
$a ok $b bmc $g 1822549 $s 1170236
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 98 $c - $d 127-132 $e 20220215 $i 1532-2653 $m Journal of clinical neuroscience $n J. clin. neurosci. $x MED00166944
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...